Stephen B. Baylin
Johns Hopkins University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Epigenetics and DNA Methylation
Strong evidence · 3 supporting papers · latest 2026
Cancer Immunotherapy and Biomarkers
Strong evidence · 3 supporting papers · latest 2023
Cancer Genomics and Diagnostics
Strong evidence · 3 supporting papers · latest 2026
Ferroptosis and cancer prognosis
Strong evidence · 3 supporting papers · latest 2026
Immune cells in cancer
Strong evidence · 2 supporting papers · latest 2026
RNA Research and Splicing
Solid evidence · 1 supporting paper · latest 2026
Histone Deacetylase Inhibitors Research
Solid evidence · 2 supporting papers · latest 2026
Immunotherapy and Immune Responses
Solid evidence · 2 supporting papers · latest 2026
Publications (9)
Derivation of CD8+ T cell infiltration potentiators in non-small-cell lung cancer through tumor microenvironment analysis
2023DOIPMID 37456850
Abstract 3278: Identification of epigenetic therapy induced tumor antigens to promote proliferation and infiltration of antigen specific T cells in non-small cell lung cancer
2022DOI
604 Clinical and molecular findings from a randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab in previously treated metastatic non-small cell lung cancer
2023DOI
Abstract 6551: Comprehensive genomic and transcriptomic analyses capture the effects of epigenetic therapy priming on immune checkpoint blockade response in non-small cell lung cancer
2024DOI
Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseases
2026DOIPMID 41779869
Epigenetic Instability–Based Metrics in Cell-Free DNA for Early Cancer Detection
2026DOIPMID 41591979
Cryo-EM structures of autoinhibited and RNA-activated ZNFX1 helicase
2026DOI
Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial
2026DOIPMID 41652014
Clinical Significance of Plasma CD9-Positive Exosomes in HIV Seronegative and Seropositive Lung Cancer Patients
2021DOIPMID 34680341
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Johns Hopkins University
Source: OpenAlex · retrieved 2026-09-29